Open House Discount Agreements for Blood Glucose Test Strips
Original notice title
Germany – Pharmaceutical products – Open house Arzneimittelrabattverträge Blutzuckerteststreifen
Opportunity Score
Why this score?
Opportunity
40 / 100
Complexity
20 / 100
Risk factors
No estimated value or framework maximum is provided, making it impossible to assess potential revenue. The actual uptak...
The open-house model is not a standard procurement, and the notice explicitly disclaims procurement law application. Le...
Deep Portfolio Analysis
Uses:
- Description
- Industries & Services
- Capabilities
- Market & Experience
- Certifications
Overview
Moderate opportunityKey Facts
- Framework procurement
- Supplies contract
- 1 lot
- Duration until Aug 2027
- Non-exclusive discount agreements for blood glucose test strips (Blutzuckerteststreifen)
- Suppliers enter into identical, non-negotiable rebate contracts
Show full summary
This is an open-house model for non-exclusive discount agreements on blood glucose test strips (Blutzuckerteststreifen) with AOK Bayern. All qualified suppliers of such test strips can join the framework, which runs from 01.09.2025 to 31.08.2027. Contracts can be concluded at any time until 03.07.2027. The procedure is not a public procurement but a voluntary arrangement under social law. No estimated value is provided. The notice serves as a standing offer to all eligible suppliers.
Risks
No estimated value or framework maximum is provided, making it impossible to assess potential revenue. The actual uptak...
The open-house model is not a standard procurement, and the notice explicitly disclaims procurement law application. Le...
Analysis may be incomplete
Only part of the procurement documentation was analyzed. Additional eligibility requirements, certificates, or submission documents may exist in the remaining tender documentation.
Key Requirements
Technical
- Must be a supplier of blood glucose test strips
Administrative
- Submit signed contract, annex 'Festlegung der vertragsgegenständlichen Arzneimittel', and self-declaration of reliability
- Submission in paper (two originals) or electronically with qualified electronic signature via the DTVP portal
Requirements may be incomplete.
Buyer
Location
München, DEU
Website
Buyer profile
Identifier
DE811695320
Activity
Health
Lots (1)
LOT-0001
Open House Discount Agreements for Blood Glucose Test Strips
Non-exclusive discount agreements for blood glucose test strips. All suppliers meeting eligibility criteria can join. Contracts start on the first of the month following submission (if complete by the 3rd) and end on 31.08.2027. The latest possible contract conclusion is 03.07.2027.
Location
Duration
Category
Deadline
Award details
Siehe kurze Beschreibung ACHTUNG: Die Vertragsunterlagen sind zwingend über den Kommunikationsbereich im Vergabeportal www.dtvp.de einzureichen und keinesfalls über den Angebotsbereich! BITTE BEACHTEN SIE: Die FRIST für einen Vertragsschluss zum nächsten Monatsersten endet jeweils am DRITTEN des Vormonats.
Value note
Show original TED data
Original lot title
Open house Arzneimittelrabattverträge Blutzuckerteststreifen
Original TED description
Siehe kurze Beschreibung ACHTUNG: Die Vertragsunterlagen sind zwingend über den Kommunikationsbereich im Vergabeportal www.dtvp.de einzureichen und keinesfalls über den Angebotsbereich! BITTE BEACHTEN SIE: Die FRIST für einen Vertragsschluss zum nächsten Monatsersten endet jeweils am DRITTEN des Vormonats.
Procurement Details
- Publication date
- 10 Jul 2025
- Languages
- German
Reference metadata
- Legal basis
- 32014L0024
Reference IDs
- Tender ID
- 452672-2025
Documents (2)
Similar tenders
Bulgaria – Pharmaceutical products – Динамична система за покупки за доставка на лекарствени продукти за Медицински институт на МВР
Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells über Arzneimittel mit dem Handelsnamen Oralair(R) (ATC-Code nach WHO: V01AA02)
Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells zum Wirkstoff Ipratropiumbromid (ATC-Code nach WHO: R03BB01)
Denmark – Pharmaceutical products – Amgros 2027 1.1170.a
Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells über Arzneimittel mit dem Handelsnamen Orylmyte(R) (ATC-Code nach WHO: V01AA03)
Germany – Pharmaceutical products – Open House Biologika Rabattverträge 2026 - 27 - Follitropin delta
Opportunity Score
Why this score?
Opportunity
40 / 100
Complexity
20 / 100
Risk factors
No estimated value or framework maximum is provided, making it impossible to assess potential revenue. The actual uptak...
The open-house model is not a standard procurement, and the notice explicitly disclaims procurement law application. Le...
Deep Portfolio Analysis
Uses:
- Description
- Industries & Services
- Capabilities
- Market & Experience
- Certifications